Zeer Ardelyx / intent / ardelyx

Ardelyx

51-250 employees·Fremont, Massachusetts, United States·ardelyx.com

Observed, not inferred · updated weekly

Buying intent

21 tracked signals | Top 14 topics are below | Marketing is carrying most of it.

21signals · 30 days
14topics tracked
69.23%attributed to a team

Attention by team

LinkedIn activity, by team

Where Ardelyx's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Healthcare Providers
CTV [Connected TV]
OTT Platforms
Patient Care
Artificial Intelligence
Patient Advocacy
Marketing
High33% of team Marketing to Healthcare Providers: High, 33% of this team's signals
High33% of team Marketing to CTV [Connected TV]: High, 33% of this team's signals
High33% of team Marketing to OTT Platforms: High, 33% of this team's signals
Marketing to Patient Care: no signal
Marketing to Artificial Intelligence: no signal
Marketing to Patient Advocacy: no signal
Others
Medium25% of team Others to Healthcare Providers: Medium, 25% of this team's signals
Others to CTV [Connected TV]: no signal
Others to OTT Platforms: no signal
Medium25% of team Others to Patient Care: Medium, 25% of this team's signals
Medium25% of team Others to Artificial Intelligence: Medium, 25% of this team's signals
Medium25% of team Others to Patient Advocacy: Medium, 25% of this team's signals
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Healthcare Providers
LinkedIn
High volume
95%
last
10d ago
CTV [Connected TV]
LinkedIn
High volume
98%
last
11d ago
OTT Platforms
LinkedIn
High volume
94%
last
11d ago
Patient Care
LinkedIn
Low volume
96%
last
10d ago
Artificial Intelligence
LinkedIn
Low volume
96%
last
10d ago
Patient Advocacy
LinkedIn
Low volume
96%
last
11d ago
Pharmaceutical
LinkedIn
Low volume
94%
last
17d ago
Fierce 15
LinkedIn
Low volume
92%
last
17d ago
Healthcare Professionals
LinkedIn
Low volume
96%
last
10d ago
Public Health
LinkedIn
Low volume
94%
last
13d ago
Women's Health
LinkedIn
Low volume
98%
last
26d ago
Nephrology
LinkedIn
Low volume
92%
last
11d ago
Gut Health
LinkedIn
Low volume
96%
last
13d ago
Conference
LinkedIn
Low volume
98%
last
10d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at Ardelyx

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others5 active
researching Healthcare Providers
in
researching Women's Health
in
researching Patient Advocacy
in
Directorresearching Public Health
in
Marketing3 active
researching Healthcare Providers
in
researching Healthcare Providers
in
Leadershipresearching CTV [Connected TV]
in

Primary products / business lines

LinkedIn company profile

Ardelyx is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). The company’s pipeline includes the Phase 3 development of IBSRELA for chronic idiopathic constipation (CIC) and R

Top accounts researching Ardelyx

names withheld on the public page

These are companies whose own people brought up Ardelyx unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

3,384 companies · 12,605 people are researching Healthcare Providers

Ardelyx's own team shows 4 signals on this topic. No one outside Ardelyx has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • CTV [Connected TV]296 cos · 655 people
  • OTT Platforms217 cos · 572 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching Ardelyx.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Marketing — 3 people; Leadership — 1 person

What's been said

public posts mentioning Ardelyx

Up to 9 public excerpts naming Ardelyx from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.

LinkedIn

Come join the Ardelyx team!!

May 2026
LinkedIn

A few months later, I'm still energized by the message Nicole Malachowski shared with the Ardelyx, Inc. Team at our National Meeting this past February...and that says everything. Her keynote on resilience, adaptability, leadership, and teamwork didn't just inspire in the moment; it sparked something that continues to grow across our organization. The conversations, the mindset shifts, the way people show up for one another...her words are still working. Two ideas in particular have taken root. The "wingman contract" — the commitment teammates make to build trust, communicate openly, and step up when it matters most — has given us a shared language for what great partnership looks like. And her concept of "harnessing headwinds" has genuinely changed how we approach challenges. Uncertainty is inevitable, but with the right mindset and the right people around you, those moments become fuel. We are so fortunate to do this work in life sciences, where every challenge we navigate and every team we strengthen has a real impact on patients' lives. Nicole's message reminded us of that purpose...and of how much more we're capable of together. Thank you, Nicole, for your generosity, your wisdom, and your belief in what teams can achieve. We're carrying it forward! 🙏

May 2026
LinkedIn

Today, we’ve announced an important leadership transition at Ardelyx: Felecia E. has joined the company as our new Chief Legal Officer. Felecia brings extensive experience in the biopharmaceutical industry, with deep expertise across legal, compliance, regulatory and government affairs. We’re excited to welcome her to Team Ardelyx, and look forward to the leadership and perspective she will bring as we continue to grow. At the same time, this is also a meaningful moment to recognize Elizabeth Grammer , who is retiring after an incredible 16 years at Ardelyx. I’ve had the privilege of working with Liz for many years, dating back to an earlier chapter in my career. Throughout that time, I’ve come to know her not only for her brilliance, but also for her deep care for the company, our employees and the patients we serve. As we built Ardelyx together, Liz was a trusted advisor to me – a steady hand, a thoughtful partner and an exceptional leader. One of the lessons from working with her that has stayed with me is to never forget to give people the opportunity to shine, to be supportive, to be direct and to always keep sight of why we do this work: to help patients. Liz, thank you for your partnership, your leadership, and your many contributions to Ardelyx. You have helped shape this company in lasting ways, and we are all better for it. We wish you all the best in your well-deserved retirement. Please join me in welcoming Felecia and congratulating Liz.

Apr 2026
LinkedInMission+

I'm hiring! The Scientific Communications team at Ardelyx is looking for an Associate Director, Medical Communications to help us deliver on our mission of improving the lives of patients. Know someone who'd be a great fit? Let's connect. #ArdelyxProud#Hiring https://lnkd.in/e5Wj5Vaw

Apr 2026
Straight from Ardelyx: 6 earnings calls and filings read in full. Leadership's own words on the public record — not analyst commentary.

Strategic priorities

Earnings call; SEC filings

Audit Data; Sales Revenue; Cash Flow; Financial Performance

What changed recently

Earnings call; SEC filings

Audit Data; Sales Revenue; Cash Flow; Financial Performance

About this data. Ardelyx (ardelyx.com). Department attribution is 69.23%; remaining activity is grouped under Others. Updated 2026-09-25T18:00:10.181Z.

Not yet computedPer-team narrative summaries